Drs. Brantly and Sacra have the same blood type, and Omaha-based Nebraska Medical Center, where Dr. Sacra is being treated, confirmed that he has received two transfusions.
Dr. Brantly, who contracted the virus in Liberia in July, was discharged in August. He was treated with an experimental drug called ZMapp. It was not confirmed, however, if the drug helped cure the disease. Dr. Brantly also received blood from an Ebola survivor.
According to officials, there is mixed evidence regarding whether blood from survivors can help Ebola patients, according to the report.
Thus far, four Americans have been infected with the virus. The virus has claimed approximately 1,848 lives as of Aug. 31, according to the Centers for Disease Control and Prevention.
More articles on quality:
Top 10 infection control stories, September 1-5
Antibiotic stewardship programs reduce hospital costs, improve outcomes
Children’s HAI rates plummet
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
